Organ Preservation Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Organ Preservation Market, By Solution

7.1.  Organ Preservation Market, By Solution Type, 2020-2030

7.1.1.    University of Wisconsin (UW)

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Custodial HTK

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Perfadex

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Organ Preservation Market, By Organ Type

8.1.  Organ Preservation Market, By Organ Type, 2020-2030

8.1.1.    Kidneys

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Liver

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Lung

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Heart

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Others

8.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Organ Preservation Market, By Preservation Technique

9.1.  Organ Preservation Market, By Preservation Technique, 2020-2030

9.1.1.    Static Cold Storage

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Hypothermic Machine Perfusion

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Normothermic Machine Perfusion

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Others

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Organ Preservation Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Solution (2016-2030)

10.1.2.  Market Revenue and Forecast, By Organ Type (2016-2030)

10.1.3.  Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Solution (2016-2030)

10.2.2.  Market Revenue and Forecast, By Organ Type (2016-2030)

10.2.3.  Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Solution (2016-2030)

10.3.2.  Market Revenue and Forecast, By Organ Type (2016-2030)

10.3.3.  Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Solution (2016-2030)

10.4.2.  Market Revenue and Forecast, By Organ Type (2016-2030)

10.4.3.  Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Solution (2016-2030)

10.5.2.  Market Revenue and Forecast, By Organ Type (2016-2030)

10.5.3.  Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Solution (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Organ Type (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Preservation Technique (2016-2030)

Chapter 11.  Company Profiles

11.1.              XVIVO Perfusion

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              TransMedics

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              21st Century Medicine

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              CryoLife, Inc

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Bridge to Life Ltd.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Report Details

  • Report Code:35233
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:November 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers